Table 3.

Number of patients (%) with non–dose-limiting non-hematologic toxicities related to protocol therapy and observed in more than 10% of 41 evaluable patients

	Maximum Grade across the Course
Toxicity Type	Grade 1	Grade 2
Rash/desquamation	4 (9.8%)	4 (9.8%)
Nausea	17 (41.5%)	3 (7.3%)
Vomiting	15 (36.6%)	6 (14.6%)
SGOT (AST)	8 (19.5%)	3 (7.3%)
SGPT (ALT)	6 (14.6%)	5 (12.2%)
Headache	3 (7.3%)	7 (17.1%)

Abbreviations: SGOT, serum glutamic oxaloacetic transaminase; AST, aspartate aminotransferase; SGPT, serum glutamic pyruvic transaminase; ALT, alanine aminotransferase.